MDGL shows dramatic deterioration across key financial metrics with total debt increasing 189% and SG&A expenses nearly doubling, despite some improvement in operating cash flow burn rate.
The massive increases in debt (189%), interest expense (263%), and SG&A costs (87%) suggest significant operational scaling challenges or distress, particularly concerning given the company's continued negative operating cash flow of $189.6M. While the improved cash burn rate and higher accounts receivable indicate some revenue growth likely from Rezdiffra launches, the overall financial picture shows a company under substantial strain.
The financial statements reveal a company experiencing dramatic cost inflation with SG&A expenses nearly doubling to $813.8M and total debt tripling to $339.9M, driving interest expense up 263%. While accounts receivable growth of 150% and improved operating cash flow burn (from -$455.6M to -$189.6M) suggest meaningful revenue generation likely from Rezdiffra commercialization, the company remains cash flow negative with significantly higher leverage and operating costs. The combination of massive debt increases, expense inflation, and continued cash burn creates a precarious financial position that requires close monitoring.
Interest expense surged 262.8% — significant debt increase or rising rates materially impacting earnings.
Debt increased 189.1% — substantial leverage increase; assess whether deployed for growth or covering losses.
Receivables surged 149.9% — revenue recognized but not yet collected; watch for collection issues or channel stuffing.
Liabilities grew 128.2% — significant increase in debt or obligations, assess impact on financial flexibility.
Inventory surged 119.7% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
Cash position surged 98.7% — strong cash generation or capital raise providing significant financial cushion.
SG&A up 87.1% — significant increase in sales or administrative costs, monitor impact on operating leverage.
Current liabilities surged 83.3% — significant near-term obligations; verify ability to meet short-term debt.
Capex reduced 68.1% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Operating cash flow surged 58.4% — exceptional cash generation, highest quality earnings signal.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →